Literature DB >> 17229901

Randomised, controlled, cross-over trial of soy protein with isoflavones on blood pressure and arterial function in hypertensive subjects.

Helena J Teede1, Dimitra Giannopoulos, Fabien S Dalais, Jonathan Hodgson, Barry P McGrath.   

Abstract

OBJECTIVE: To examine the effects of dietary soy/isoflavones on 24 hr blood pressure profiles and arterial function [systemic arterial compliance (SAC), pulse wave velocity (PWV) and brachial arterial flow mediated vasodilation (FMD)] compared to non legume-based plant protein without isoflavones, in hypertensive subjects.
DESIGN: In a 6 month double-blind, placebo controlled, cross-over trial, 41 hypertensive subjects (26 men, 15 postmenopausal women), 30-75 years, received soy cereal (40 g soy protein, 118 mg isoflavones) and gluten placebo cereal, each for 3 months.
RESULTS: Thirty-eight subjects completed protocol with results expressed as mean or mean change (+/-SEM) with each intervention. Soy increased urinary isoflavones (daidzein: 8-fold; genistein: 8-fold; equol: 9-fold; ODMA: 18-fold) with no change during gluten placebo. There was no difference in the change in individual 24 hr ambulatory BP parameters (SBP: 2 +/- 2 vs -1 +/- 1 mmHg, p = 0.21; DBP: 1 +/- 1 vs -1 +/- 1 mmHg, p = 0.06) central BP (cSBP: -4 +/- 2 vs 0 +/- 2 mmHg, p = 0.2) or the change in arterial function (FMD: 0.3 +/- 0.5 vs -0.2 +/- 0.5%, p = NS; SAC: 0.02 +/- 0.02 vs -0.02 +/- 0.02 U/mmHg, p = NS; PWV central: -0.2 +/- 0.2 vs 0.0 +/- 0.2 m/sec, p = NS; PWV peripheral: 0.01 +/- 0.3 vs -0.4 +/- 0.4 m/sec, p = NS) noted between interventions. Analysis of the area under curve of 24 hr BP outputs demonstrated that soy protein compared to gluten protein resulted in higher 24 hr systolic BP by 2.3 mmHg (p = 0.003), a higher daytime systolic BP by 3.4 mmHg (p = 0.0002) and a higher daytime diastolic BP by 1.4 mmHg (p = 0.008). Overall 24 hr diastolic BP, night systolic BP and night diastolic BP were not significantly different between groups. Furthermore, soy protein compared to gluten protein resulted in higher 24 hr heart rates by 3.5 bpm (p < 0.0001).
CONCLUSIONS: In hypertensive subjects, compared to gluten placebo, soy dietary supplementation containing isoflavones had no effect on arterial function, on average 24 hr ambulatory blood pressure parameters or central blood pressure in men and women with hypertension. Area under the curve of 24 hr profiles demonstrated that daytime BP was higher after soy compared to gluten.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17229901     DOI: 10.1080/07315724.2006.10719569

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  14 in total

Review 1.  Sex differences in mechanisms of arterial stiffness.

Authors:  Jennifer J DuPont; Rachel M Kenney; Ayan R Patel; Iris Z Jaffe
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

2.  Antihypertensive effects of dietary protein and its mechanism.

Authors:  Sudesh Vasdev; Jennifer Stuckless
Journal:  Int J Angiol       Date:  2010

Review 3.  The role of nutrition and nutraceutical supplements in the treatment of hypertension.

Authors:  Mark Houston
Journal:  World J Cardiol       Date:  2014-02-26

Review 4.  Review article: health benefits of some physiologically active ingredients and their suitability as yoghurt fortifiers.

Authors:  A E Fayed
Journal:  J Food Sci Technol       Date:  2014-05-07       Impact factor: 2.701

5.  NutriGenomeDB: a nutrigenomics exploratory and analytical platform.

Authors:  Roberto Martín-Hernández; Guillermo Reglero; José M Ordovás; Alberto Dávalos
Journal:  Database (Oxford)       Date:  2019-01-01       Impact factor: 3.451

6.  Genistein induces estrogen-like effects in ovariectomized rats but fails to increase cardiac GLUT4 and oxidative stress.

Authors:  Layla Al-Nakkash; Brandon Markus; Lyn Batia; Walter C Prozialeck; Tom L Broderick
Journal:  J Med Food       Date:  2010-10-18       Impact factor: 2.786

Review 7.  Targeting vascular (endothelial) dysfunction.

Authors:  Andreas Daiber; Sebastian Steven; Alina Weber; Vladimir V Shuvaev; Vladimir R Muzykantov; Ismail Laher; Huige Li; Santiago Lamas; Thomas Münzel
Journal:  Br J Pharmacol       Date:  2016-07-04       Impact factor: 8.739

8.  Urinary isoflavonoids and risk of coronary heart disease.

Authors:  Xianglan Zhang; Yu-Tang Gao; Gong Yang; Honglan Li; Qiuyin Cai; Yong-Bing Xiang; Bu-Tian Ji; Adrian A Franke; Wei Zheng; Xiao-Ou Shu
Journal:  Int J Epidemiol       Date:  2012-08-27       Impact factor: 7.196

Review 9.  Effects of botanical dietary supplements on cardiovascular, cognitive, and metabolic function in males and females.

Authors:  Scott Carlson; Ning Peng; Jeevan K Prasain; J Michael Wyss
Journal:  Gend Med       Date:  2008

10.  Effects of isoflavone-containing soya protein on ex vivo cholesterol efflux, vascular function and blood markers of CVD risk in adults with moderately elevated blood pressure: a dose-response randomised controlled trial.

Authors:  Chesney K Richter; Ann C Skulas-Ray; Jennifer A Fleming; Christina J Link; Ratna Mukherjea; Elaine S Krul; Penny M Kris-Etherton
Journal:  Br J Nutr       Date:  2017-05       Impact factor: 3.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.